Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $331.4M $301.9M $293.5M $301.6M $283.7M
Cost of Revenue $169.2M $164.1M $157.9M $176.1M $206.3M
Gross Profit $162.1M $137.8M $135.5M $125.5M $77.4M
Gross Margin 48.9% 45.6% 46.2% 41.6% 27.3%
Operating Expenses
Research & Development $18.1M $12.2M $14.4M $13.7M $30.5M
SG&A Expense $49.8M $38.8M $43.9M $37.3M $33.0M
Operating Income $51.9M $56.6M $42.5M $39.4M $-18.9M
Operating Margin 15.6% 18.7% 14.5% 13.1% -6.7%
Interest Expense $18.4M $26.6M $38.7M $42.3M $42.9M
Pretax Income $39.6M $28.3M $-11.8M $-2.4M $-60.5M
Income Tax Expense $-83.7M $1.5M $3.0M $1.2M $1.0M
Net Income $123.4M $26.8M $-14.7M $-3.6M $-61.6M
Net Margin 37.2% 8.9% -5.0% -1.2% -21.7%
EPS (Basic) $3.31 $0.84 $-0.60 $-0.20 $-3.42
EPS (Diluted) $3.17 $0.82 $-0.60 $-0.20 $-3.42
Shares Outstanding (Basic) 37.3M 32.0M 24.4M 18.1M
Shares Outstanding (Diluted) 38.9M 32.7M 24.4M 18.1M
Dividends Per Share
← Newer Page 2 of 2 Older →